Juvea Medical on Harley Street has become the first clinic in the UK to offer the body contouring laser treatment SculpSure for the submental area.
A clinical study conducted by global pharmaceutical company Allergan suggests that higher doses of Botox Cosmetic (onabotulinumtoxinA) to treat moderate to severe glabella lines produces greater duration of treatment effect.
We find out how the Venus Freeze painlessly achieves significant rejuvenation and body shaping results.
Plastic surgeon Mr Mauricio de Maio is unveiling two new dermal filler injection techniques to treat the chin and jawline, in conjunction with global pharmaceutical company Allergan.
A study conducted by the Food and Drug Administration (FDA) has revealed that many common sunscreen ingredients can result in exposure levels which exceed the FDA threshold for safety testing.
Aesthetic device manufacturer BTL Aesthetics has released its latest non-invasive body sculpting device, the EMsculpt.
Global aesthetic manufacturer Teoxane Laboratories has announced that the US Food and Drug Administration (FDA) has approved three of its dermal fillers.
The Food and Drug Administration (FDA) has announced a public warning of unapproved versions of Juvéderm.
Aesthetic distributor Merz Aesthetics will introduced a new cellulite treatment to the UK and Ireland in early 2017.
New educational content from the UK’s leading medical aesthetic companies has been confirmed for the Aesthetics Conference and Exhibition (ACE) on March 13 and 14.